I think it might go up a little bit, but no where near $19. Like I was saying before, it appears to me now, that it's not just FDA approval, but getting it on the shelves and in the doctors hands and not just having sales, but also having profits that make biotech stocks go up nowadays.
Also, I don't think Lipocine has enough money to bring this to market, hence a partner or a bad situation of stock dilution, to bring in cash for selling, general and administrative and marketing costs.
Of course I could be wrong, or only partially correct, these are not absolute truths.
I hate to take a guess, but if Tlando gets approved, I think the stock price will go up to $2.50 and after that I have no idea where it will go from there, will it maintain, go up, fluctuate up and down, or skyrocket up and blast off?
My take on this, is that it's a long term investment and within 5 years, if Lipocine goes it alone, it will be highly profitable.
I would like to see a buy out of Lipocine for a quicker profit for us, if not that, then a partnership.
News 
Market Data 
Discover 
AI
